BevCanna Enterprises Inc. (CSE:BEV) (“BevCanna” or the “Company”) announced that its board of directors has appointed Michael Darby as the Chief Financial Officer and Corporate Secretary of the Company, effective July 29, 2019. Mr. Darby succeeds John Campbell, who will continue to hold the role of Chief Strategy Officer of the Company, and who will now focus primarily on merger, acquisition and joint venture opportunities in BevCanna’s two principal markets, Canada and California.

“We’re pleased that Michael has joined the BevCanna team,” said Marcello Leone, CEO of BevCanna. “Michael’s extensive financial management expertise will be an invaluable asset to our team, especially in this period of strategic expansion. His stewardship capabilities across a range of industries, and particularly in the capital markets arena, will be critical as we move forward with our long-term plans.”

“It’s an exciting opportunity that I couldn’t pass up,” noted Mr. Darby. “The cannabis-infused beverage market is on the brink of explosive growth, and BevCanna is at the forefront of the industry. To join a team with the branding, beverage and cannabis expertise that this team jointly holds is very appealing.”

A finance professional with over 25 years of progressively senior financial management experience, Mr. Darby joins BevCanna from Naturo Group Investments Inc. Prior to joining Naturo Group, Mr. Darby served as Chief Financial Officer of Skidmore Group Holdings Inc., a family-owned private equity firm. Previous roles include CFO of TCG International Inc., an international manufacturer, retailer and franchisor of auto & window glass, and Canadian manufacturer & distributor of architectural millwork, and Corporate Controller & Director of Administration of Glentel Inc., a publicly-traded retail telecommunications company.

Mr. Darby is a member of the Chartered Professional Accountants of British Columbia and earned a Bachelor of Commercial Studies degree from the University of Western Ontario.

About BevCanna

BevCanna Enterprises Inc. (CSE: BEV) plans to develop and manufacture cannabinoid-infused beverages and consumer products for in-house brands and white label clients. With decades of experience creating, branding and distributing iconic brands that have resonated with consumers on a global scale, the team demonstrates an expertise unmatched in the emerging cannabis beverage category. Based in British Columbia, Canada, BevCanna has a 100-acre outdoor cultivation site in the fertile Okanagan Valley and the exclusive rights to a pristine spring water aquifer, as well as a world-class 40,000-square-foot, HACCP certified manufacturing facility, with a current bottling capacity of up to 72M bottles. BevCanna’s vision is to be a global leader in infused innovations.

Disclaimer for Forward-Looking Information

Certain information in this news release constitutes forward-looking statements under applicable securities laws. Any statements that are contained in this news release that are not statements of historical fact are forward-looking statements. Forward looking statements are often identified by terms such as “may”, “should”, “anticipate”, “expect”, “potential”, “believe”, “intend”, “estimate” or the negative of these terms and similar expressions. Forward-looking statements in this news release include, but are not limited to: that Michael Darby’s extensive financial management expertise will be an invaluable asset to the Company, especially in this period of strategic expansion, and that his stewardship capabilities across a range of industries, and particularly in the capital markets arena, will be critical as the Company moves forward with its long-term plans; the cannabis-infused beverage market is on the brink of explosive growth; statements with respect to the development and manufacturing of cannabinoid-infused beverages and consumer products for in-house brands and white label clients; the emerging cannabis beverage category; and the business plans of the Company

Forward-looking statements are based on certain assumptions regarding that Michael Darby’s experience will benefit the Company; anticipated changes to Canadian federal legislation to legalize cannabis infused beverages; and expectations with respect to the future growth of recreational cannabis products. Readers are cautioned not to place undue reliance on forward-looking statements. The assumptions of the Company, although considered reasonable by it at the time of preparation, may prove to be incorrect. In addition, forward-looking statements necessarily involve known and unknown risks, including, without limitation, risks associated with: adverse market conditions; changes to the growth and size of the cannabis-infused beverage markets; consumer acceptance and adoption of cannabis-infused beverages as compared to other beverages; future legislative and regulatory developments and other risks. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Click here to connect with Bevcanna Enterprises Inc. (CSE:BEV) for an Investor Presentation


American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less